Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

J&J looks to trim business with $2.8bn sale

June 7, 2018 Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

Johnson & Johnson continues to look at options to slim down its business, after having received an offer from Fortive …
News

Pfizer pumps $600m into venture fund, targeting neuroscience

June 7, 2018 Research and Development, Sales and Marketing Pfizer, biotech, drugs, neuroscience, pharma, pharmaceutical

Pfizer’s move to dump its neuroscience divisions caused serious ripples through the industry, with many wondering whether it heralded an …
News
money-2180330_960_720

Forty Seven springs out of the blocks ahead of IPO

June 7, 2018 Research and Development, Sales and Marketing Forty Seven, biotech, drugs, pharma, pharmaceutical

Forty Seven, a spinout from Stanford University, has had a busy few days – first announcing that it had filed …
News
handshake2

Axovant attempts to rise from ashes with $842m Parkinson’s therapy deal

June 7, 2018 Sales and Marketing Axovant, Oxford BioMedica, biotech, drugs, pharma, pharmaceutical

Axovant’s spectacular crash to Earth, after a soaring IPO that saw its share price hit the heady heights of $26, …
News

FlyPharma Conference Europe concludes its fourth successful year in Brussels

June 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, flypharma, pharma, pharmaceutical

The FlyPharma Conference Europe wrapped up for another year on 6 June, returning with an expanded roster of speakers who …
News
mylan_inside_0

Mylan lands biosimilar sucker punch to Amgen’s blockbuster

June 6, 2018 Research and Development, Sales and Marketing Amgen, Biocon, Mylan, Neulasta

Mylan and Biocon have received FDA approval for their biosimilar to Amgen’s Neulasta (pegfilgrastim), setting the companies on track to …
News
bill_hinshaw

Novartis’ US Oncology head makes leap to become biotech CEO

June 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

The departure of high-level, big pharma executives to tiny biotechs is steadily becoming a constant stream; the latest is Bill …
Appointment
david_elkins

Celgene bring in new CFO to steady the ship

June 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene

The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …
Appointment
lilly_building_with_american_flag_web

FDA greenlights Lilly’s Olumiant in rheumatoid arthritis, with major caveats

June 5, 2018 Manufacturing and Production, Sales and Marketing Eli Lilly, FDA, Olumiant, pharma

Eli Lilly has announced that its oral JAK inhibitor Olumiant (baricitinib) has received FDA approval for the treatment of moderately-to-severely …
News
2000px-gastric_balloon_icon

FDA links intragastric balloons to 5 more deaths, bringing total to 12 since 2016

June 5, 2018 Manufacturing and Production, Sales and Marketing FDA, gastric balloon, pharma

Five more deaths have been reported to the FDA in patients using intragastric balloon systems, meaning that 12 total deaths …
News
janssen_latest_logo_on_sign_closer

Janssen debuts promising new cancer data at ASCO

June 4, 2018 Research and Development, Sales and Marketing ASCO, Cancer, J&J, JJ, Jassen, erdafitinib, imbruvica, pharma

Janssen took the opportunity at the American Society of Clinical Oncology (ASCO) annual event to present promising new Phase 2 …
News
roche

Roche’s breast, lung cancer offerings fail to impress at ASCO

June 4, 2018 Research and Development, Sales and Marketing ASCO, Cancer, Roche, breast cancer, lung cancer, pharma, taselisib, tecentriq

Roche made an underwhelming impact at the American Society of Clinical Oncology (ASCO) annual event in Chicago, after revealing data …
News
diana-bracco-100-01

Milan’s decision to appeal the EMA HQ relocation explained

June 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Milan, biotech, drugs, pharma, pharmaceutical

The decision to award the EMA headquarters to Amsterdam was a contentious one, not least because the vote had to …
Feature
novartis_side_building

Amgen/Novartis migraine med gets CHMP nod

June 4, 2018 Sales and Marketing Aimovig, Amgen, Novartis, biotech, drugs, pharma, pharmaceutical

Amgen and Novartis have announced that their newly FDA-approved treatment for migraines has received a recommendation from the CHMP, generally …
News
doctor_notes

Keytruda offers significant hope in subset of prostate cancer

June 4, 2018 Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, prostate cancer

Up until present, no studies had shown that immunotherapies could offer potential treatment for men with prostate cancer; however, at …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026